K E Y W W W.C M O L E A D E R S H I PA W A R D S .C O M
2016
CMO
LEADERSHIP
AWARDS
WINNERS
Company
Profiles
LIFESCIENCELEADER.COM
THE CMO LEADERSHIP AWARDS 2016
61
CAPABILITIES COMPATIBILITY EXPERTISE QUALITY RELIABILITY
INDIVIDUAL ATTRIBUTE AWARDS: accessible
senior management, on-time, right first time, state-
of-the-art
INDIVIDUAL ATTRIBUTE AWARDS: accessible
senior management, right first time, strength of
science
INDIVIDUAL ATTRIBUTE AWARDS: accessible
senior management, innovation, right first time,
state-of-the-art
DRUG TYPE:
Biopharmaceuticals
DRUG TYPE:
Pharmaceuticals
DRUG TYPE:
Pharmaceuticals
DRUG LIFE CYCLE STAGES:
Research & Development: Clinical (Phase 1,
Phase 2, Phase 3)
Drug Substance Production: Drug Substance
Production
Formulated Drug Production: Dosage Form
Production, Packaging, Logistics
DRUG LIFE CYCLE STAGES:
Research & Development: Discovery, Preclinical,
Clinical (Phase 1, Phase 2, Phase 3)
Drug Substance Production: Primary Process
Development, Drug Substance Production
Formulated Drug Production: Dosage Form
Development, Dosage Form Production,
Packaging, Logistics
DRUG LIFE CYCLE STAGES:
Research & Development: Preclinical, Clinical
(Phase 1, Phase 2, Phase 3)
Drug Substance Production: Primary Process
Development
"It is a great honor to be recognized as the
winner of a 2016 CMO Leadership Award. With
sustainable growth and successful installation
of quality system & culture, Samsung BioLogics
has become a strategic manufacturing partner
to global big pharmas. With our world's best
manufacturing facilities, providing full services
through clinical to commercial and drug substance
to drug product, we will put our utmost efforts to
maximize customer satisfaction."
"Recognition in all five categories is a true testament
to our entire team. Siegfried has transformed over
the past five years to become a leading, integrated
drug substance and drug product service partner.
We provide products and tailor-made services that
support our customers' entire value chain. Whether
it's custom development services producing APIs
and drug products (oral or sterile) or controlled
substances and higher potency you desire, I can
assure you, Siegfried is the right partner for you."
"I'm very proud that WuXi's STA is a 2016 CMO
Leadership Award recipient in four categories.
As an emerging world-leading CDMO, we strive
to provide our customers the highest quality of
services with our state-of-the-art facilities, efficient
R&D; and manufacturing processes, as well as
talented people. We look forward to expanding
our capabilities and capacities with the newly
opened facilities in Changzhou, China to better
serve our partners."
SERVICES & CAPABILITIES: aseptic fill/finish,
injectables, liquids, lyophilized products,
proteins, syringes (prefilled)
SERVICES & CAPABILITIES: aseptic fill/finish,
capsules, cartridges, controlled substances, gels,
high containment compounds, injectables, non-
sterile, opthalmics, parenterals (large volume),
parenterals (small volume), solid dose, solutions &
suspensions, sterile, sustained release
SERVICES & CAPABILITIES: cytotoxic & high
potency compounds, powders (nonsterile),
powders (sterile), solid dose
TH KIM
President & CEO
DR. RUDOLF HANKO
CEO
MINZHANG CHEN
CEO, Sr. VP
CATEGORIES WON CATEGORIES WON CATEGORIES WON
STA, a WuXi AppTec company
Shanghai, China
www.stapharma.com
+1 651 675 2000 Ext. 2324
Yu Lu
yu.lu@wuxiapptec.com
Key locations: Shanghai WaiGaoQiao Free Trade
Zone; Jinshan, Shanghai; Changzhou, Jiangsu
Siegfried AG
Zofingen, Argau Switzerland
www.siegfried.ch
+41 62 7461520
Marianne Spaene
marianne.spaene@siegfried.ch
Key locations: Switzerland, France, Germany,
China, Malta, Pennsville, NJ, Irvine, CA, U.S.A.
Samsung BioLogics
Incheon, South Korea
www.samsungbiologics.com
+82 32 455 3112
Emily Kwon
youyoung.kwon@samsung.com
Key locations: Incheon, Korea (Plants 1, 2, & 3)